What We're Reading: Page 57
Industry reads hand-picked by our editors
Feb 08, 2024
-
Bloomberg
AstraZeneca’s Outlook Disappoints Amid Profit Margin Concern
-
Axios
How a company cut health spending by nearly half
-
The Transmitter
U.S. government requested inquiry into Alzheimer’s scientist over misconduct allegations
-
Wired
A Study at the Center of the Abortion Pill Battle Was Just Retracted
Feb 07, 2024
-
Financial Times
Eli Lilly calls for scrutiny of rival Novo Nordisk’s deal to expand production of weight-loss drug
-
Reuters
US FDA finds control lapses at Catalent plant being sold to Novo
-
Axios
Biden admin pushes pharmacy execs on COVID treatment Paxlovid costs
-
C&EN
Lawmakers introduce bill to fix the Inflation Reduction Act’s ‘small-molecule penalty’
Feb 06, 2024
Feb 05, 2024
-
AP News
As investors pile into psychedelics, idealism gives way to pharma economics
-
Bloomberg
Generic Drugs Made in India Rely Heavily on Chinese-Made Ingredients
-
Axios
Biotech is the new focus in U.S.-China tech rivalry
-
Nature News
Elon Musk’s Neuralink brain chip: what scientists think of first human trial
Feb 02, 2024
-
The Boston Globe
New ICER boss Sarah Emond keeps an eye on the bottom line
-
ApexOnco
Takeda thins the cell therapy pipeline
-
Financial Times
Ovaries are an enigma that could unlock human lifespan
-
The Wall Street Journal
Ad Agency Publicis Health to Pay $350 Million Over Opioid Marketing
Feb 01, 2024
-
CNN
Medicare drug price negotiations begin after Biden administration makes initial offers
-
The Boston Globe
Kendall Square is no longer the area’s only biotech hotspot
-
The Wall Street Journal
23andMe’s Fall From $6 Billion to Nearly $0
-
Philadelphia Business Journal
Lawsuit accuses Penn and Dr. James Wilson of illegal conduct and ‘sabotage’
Jan 31, 2024
-
Axios
“Hungry gut” vs. “hungry brain”: Test could help decide who gets obesity drugs
-
Washington Business Journal
Novavax laying off another 12% of its workforce
-
Barron’s
Teva Plans to Divest Drug Ingredients Business in Next Step of Strategic Shift
-
The New York Times
Who Gets Left Behind When Gene Therapy Cures a Disease?
Previous
